ARNI (Arno Therapeutics) E10: $-2.36 (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Arno Therapeutics E10?

Arno Therapeutics ARNI E10 is $-2.36 as of Sep. 2016.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Arno Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2016 was $-0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.36 for the trailing ten years ended in Sep. 2016.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-01), Arno Therapeutics's current stock price is $0.0001. Arno Therapeutics's E10 for the quarter that ended in Sep. 2016 was $-2.36. Arno Therapeutics's Shiller PE Ratio of today is .


Arno Therapeutics  (OTCPK:ARNI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Arno Therapeutics E10 Related Terms


Arno Therapeutics E10 Historical Data

* Premium members only.

The historical data trend for Arno Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arno Therapeutics E10 Chart

Arno Therapeutics Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.30 -2.35

Arno Therapeutics Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.36 -2.35 -2.32 -2.35 -2.36

ARNI vs PLPL, BTHE, WIZP: E10 Comparison

For the Biotechnology subindustry, Arno Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arno Therapeutics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arno Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Arno Therapeutics's Shiller PE Ratio falls into.



Arno Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arno Therapeutics's adjusted earnings per share data for the three months ended in Sep. 2016 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2016 (Change)*Current CPI (Sep. 2016)
=-0.09/241.4280*241.4280
=-0.090

Current CPI (Sep. 2016) = 241.4280.

Arno Therapeutics Quarterly Data

per share eps CPI Adj_EPS
200603 -0.017 199.800 -0.021
200606 -0.018 202.900 -0.021
200609 -0.017 202.900 -0.020
200612 -0.014 201.800 -0.017
200703 -0.020 205.352 -0.024
200706 -0.021 208.352 -0.024
200709 -1.040 208.490 -1.204
200712 -1.040 210.036 -1.195
200803 -0.090 213.528 -0.102
200806 -2.320 218.815 -2.560
200809 -0.880 218.783 -0.971
200812 -1.200 210.228 -1.378
200912 0.000 215.949 0.000
201003 -0.320 217.631 -0.355
201006 -0.480 217.965 -0.532
201009 -0.480 218.439 -0.531
201012 -0.320 219.179 -0.352
201103 -0.640 223.467 -0.691
201106 -0.400 225.722 -0.428
201109 -0.400 226.889 -0.426
201112 -0.480 225.672 -0.514
201203 -0.560 229.392 -0.589
201206 -0.080 229.478 -0.084
201209 -0.660 231.407 -0.689
201212 -1.880 229.601 -1.977
201303 -0.210 232.773 -0.218
201306 -2.350 233.504 -2.430
201309 -0.750 234.149 -0.773
201312 -1.165 233.049 -1.207
201403 -0.020 236.293 -0.020
201406 0.140 238.343 0.142
201409 0.010 238.031 0.010
201412 0.180 234.812 0.185
201503 -0.170 236.119 -0.174
201506 -0.170 238.638 -0.172
201509 -0.030 237.945 -0.030
201512 -0.190 236.525 -0.194
201603 -0.100 238.132 -0.101
201606 -0.050 241.018 -0.050
201609 -0.090 241.428 -0.090

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-2.36 mean?
Arno Therapeutics (ARNI) has a E10 of $-2.36 as of Sep. 2016. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Arno Therapeutics and its competitors.
Is Arno Therapeutics' E10 too high?
Arno Therapeutics' current E10 is $-2.36.
How does Arno Therapeutics' E10 compare to PLPL and BTHE?
Arno Therapeutics' E10 of $-2.36 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Arno Therapeutics and its competitors. Arno Therapeutics's current E10 is $-2.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arno Therapeutics stock overvalued right now?
Arno Therapeutics (ARNI) has a current E10 of $-2.36. The current E10 is $-2.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Arno Therapeutics (ARNI), the current E10 is $-2.36 as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arno Therapeutics Business Description

Address 200 Route 31 North, Suite 104, Flemington, NJ, USA, 08822
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.